Company culture of my dreams - Anonymous employee GoodRx Employee Review

5.0
Apr 4, 2018
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

I got this job with no expectation at all, just needed a place to start since I got notice I was being laid off. I was more than pleasantly surprised to find that this place was a manifestation of everything I'd wanted in a job. Casual work environment, amazing company culture, work sponsored happy hours, catered lunches, and the flexibility to work from home when needed. Unlimited PTO doesnt hurt and it's great that everyone has the opportunity to rub elbows with the CEO's. The company itself is doing something really really good for people...it's not a perfect system by any means but the fact that what we do helps a lot of people makes the bad days a little bit better. I'm also driven by the idea that there is room for growth. I love working here and I hope to continue to grow and develop my career with GoodRx.

Cons

I'm not being paid enough but I'm working on changing that. Certain departments seem to be very isolated from the rest so it takes an extroverted person to truly get to know everyone. I wish there was more emphasis on getting different departments together.

Explore other reviews about GoodRx

5.0
May 14, 2026
Recommend
CEO approval
Business Outlook

Pros

Great space to learn, encouraged learning from mistakes, great overall positive attitude and collaboration amongst eng and non-eng co-workers

Cons

Started to feel more of a company that started prioritizing profits and started to think of several products to ship out without much support for the reason or long term support to improve the products.

1
4.0
Jun 23, 2026
Recommend
CEO approval
Business Outlook

Pros

Great compensation and benefits. Extreme work flexibility. Mission driven work where you know your directly helping Americans access important health care. Company is taking a great measured approach to AI adoption.

Cons

GoodRx is an established dominant player in the prescription drug space and is starting to flounder a bit in the face of stiff, more digital first, competition. Unclear what the future holds and this is reflected in the stock price. As such project direction can be a bit vague. Similarly a long history of tech debt, further muddled by HIPAA requirements, can make product development painful.

See reviews by: Helpful|Rating|Date|All